Rubicon Organics Stock Fundamentals
| ROMJ Stock | CAD 0.33 0.01 3.13% |
Rubicon Organics fundamentals help investors to digest information that contributes to Rubicon Organics' financial success or failures. It also enables traders to predict the movement of Rubicon Stock. The fundamental analysis module provides a way to measure Rubicon Organics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Rubicon Organics stock.
At this time, Rubicon Organics' Other Operating Expenses is fairly stable compared to the past year. Total Revenue is likely to climb to about 43.2 M in 2024, whereas Interest Expense is likely to drop slightly above 998.4 K in 2024. Rubicon | Select Account or Indicator |
Rubicon Organics Company Return On Equity Analysis
Rubicon Organics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Rubicon Organics Return On Equity | -0.0933 |
Most of Rubicon Organics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rubicon Organics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Rubicon Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for Rubicon Organics is extremely important. It helps to project a fair market value of Rubicon Stock properly, considering its historical fundamentals such as Return On Equity. Since Rubicon Organics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Rubicon Organics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Rubicon Organics' interrelated accounts and indicators.
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Rubicon Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Rubicon Organics has a Return On Equity of -0.0933. This is 99.61% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The return on equity for all Canada stocks is 69.9% lower than that of the firm.
Rubicon Organics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Rubicon Organics's current stock value. Our valuation model uses many indicators to compare Rubicon Organics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rubicon Organics competition to find correlations between indicators driving Rubicon Organics's intrinsic value. More Info.Rubicon Organics is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . At this time, Rubicon Organics' Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Rubicon Organics' earnings, one of the primary drivers of an investment's value.Rubicon Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rubicon Organics' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Rubicon Organics could also be used in its relative valuation, which is a method of valuing Rubicon Organics by comparing valuation metrics of similar companies.Rubicon Organics is rated second in return on equity category among its peers.
Rubicon Organics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Rubicon Organics from analyzing Rubicon Organics' financial statements. These drivers represent accounts that assess Rubicon Organics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Rubicon Organics' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 69.8M | 158.9M | 101.6M | 43.3M | 49.8M | 47.3M | |
| Enterprise Value | 81.0M | 160.7M | 99.8M | 45.2M | 52.0M | 49.4M |
Rubicon Fundamentals
| Return On Equity | -0.0933 | ||||
| Return On Asset | -0.025 | ||||
| Profit Margin | (0.08) % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 19.77 M | ||||
| Shares Outstanding | 56.48 M | ||||
| Shares Owned By Insiders | 53.51 % | ||||
| Shares Owned By Institutions | 3.88 % | ||||
| Number Of Shares Shorted | 9 | ||||
| Price To Book | 0.50 X | ||||
| Price To Sales | 0.45 X | ||||
| Revenue | 41.12 M | ||||
| Gross Profit | 1.51 M | ||||
| EBITDA | 845.83 K | ||||
| Net Income | (5.49 M) | ||||
| Cash And Equivalents | 4.22 M | ||||
| Cash Per Share | 0.08 X | ||||
| Total Debt | 758.46 K | ||||
| Debt To Equity | 0.22 % | ||||
| Current Ratio | 6.35 X | ||||
| Book Value Per Share | 0.67 X | ||||
| Cash Flow From Operations | 6.79 M | ||||
| Earnings Per Share | (0.08) X | ||||
| Target Price | 1.1 | ||||
| Number Of Employees | 180 | ||||
| Beta | 1.12 | ||||
| Market Capitalization | 18.36 M | ||||
| Total Asset | 56.11 M | ||||
| Retained Earnings | (89.7 M) | ||||
| Working Capital | 19.32 M | ||||
| Net Asset | 56.11 M |
About Rubicon Organics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rubicon Organics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rubicon Organics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rubicon Organics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Total Revenue | 41.1 M | 43.2 M | |
| Cost Of Revenue | 29.9 M | 31.4 M | |
| Stock Based Compensation To Revenue | 0.03 | 0.03 | |
| Sales General And Administrative To Revenue | 0.09 | 0.08 | |
| Capex To Revenue | 0.06 | 0.06 | |
| Revenue Per Share | 0.71 | 0.75 | |
| Ebit Per Revenue | (0.03) | (0.03) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Rubicon Stock Analysis
When running Rubicon Organics' price analysis, check to measure Rubicon Organics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rubicon Organics is operating at the current time. Most of Rubicon Organics' value examination focuses on studying past and present price action to predict the probability of Rubicon Organics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rubicon Organics' price. Additionally, you may evaluate how the addition of Rubicon Organics to your portfolios can decrease your overall portfolio volatility.